Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting3
Other1

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT07487883Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
Malignant NeoplasmNon-Small Cell Lung CancerPET/CT+1 more
StudydirectorStart date: 2026-03-18
NCT07498933Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
Neoadjuvant TherapyNon-Small Cell Lung CancerPET/CT
StudydirectorStart date: 2025-06-03
NCT06930807Not ApplicableRecruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
Adaptive TreatmentMinimal Residual DiseaseNon-small Cell Lung Cancer
StudychairStart date: 2025-03-25
Multiplex Analysis of Circulating Tumor DNA
CarcinomaLung NeoplasmNon-small-cell Lung Cancer
StudydirectorStart date: 2019-04-11

Research Network

Collaboration Network

18 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hao Li, MD

Peking University People's Hospital

Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTCancer+2 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 2 trials
Similarity Score58%

Yuan Li, MD

Peking University People's Hospital

Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTCancer+2 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 2 trials
Similarity Score58%

Jun Wang, M.M.

Peking University People's Hospital

Similar
3 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungPET/CTCancer+2 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 2 trials
Similarity Score58%

Xing Yang, MD

Peking University People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CancerCarcinoma, Non-Small-Cell LungPET/CT+1 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score44%

Ziqian Bai, MD

Peking University People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

CancerCarcinoma, Non-Small-Cell LungPET/CT+1 more

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score44%

Xiaojun Zhu, PhD

China National Institute for Occupational Safety and Health (NIOSH/CDC)

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Moderately Similar
19 trials

Shared therapeutic areas:

Neoadjuvant TherapyCarcinoma, Non-Small-Cell LungPET/CT

Worked with same sponsors:

Peking University People's Hospital
Collaborated on 1 trial
Similarity Score34%

Ziming Li, MD

Shanghai Chest Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungAdaptive TreatmentNeoplasm, Residual

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Jun Yin, MD

Shanghai Zhongshan Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Rong Yin, MD

Jiangsu Cancer Institute & Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT07487883StudyDirector

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Malignant NeoplasmNon-Small Cell Lung CancerPET/CT+1 more
Recruiting
NCT07498933StudyDirector

FAP-targeted PET/NIR in Lung Malignant Tumors

Neoadjuvant TherapyNon-Small Cell Lung CancerPET/CT
Recruiting
NCT06930807Not ApplicableStudyChair

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Adaptive TreatmentMinimal Residual DiseaseNon-small Cell Lung Cancer
Recruiting
NCT03301961StudyDirector

Multiplex Analysis of Circulating Tumor DNA

CarcinomaLung NeoplasmNon-small-cell Lung Cancer
Unknown

All 4 trials loaded